Putting caution in TEAM: high-dose chemotherapy with autologous HSCT for primary central nervous system lymphoma

Bone Marrow Transplant. 2012 Oct;47(10):1383-4. doi: 10.1038/bmt.2012.48. Epub 2012 Mar 19.

Authors

R L Tombleson, M R Green, K M Fancher

PMID: 22426753
DOI: 10.1038/bmt.2012.48

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Central Nervous System Neoplasms / therapy*
Humans
Lymphoma, Non-Hodgkin / therapy*
Stem Cell Transplantation*